December 11, 2017

One of the least well-known but most promising areas of drug research is the creation of generic biologic medicines, or biosimilars. These drugs have great potential and often offer the best treatments for serious diseases such as cancer, HIV/AIDsS, rheumatoid arthriti...

December 5, 2017

In January 2017, the eyewear company Luxottica announced it would acquire Essilor, a large French company that produces ophthalmic lenses and other equipment, for $53 billion. The two companies were confident that they could merge without much trouble and that antitrus...

December 4, 2017

On September 30th, funding for the Children's Health Insurance Program (CHIP), which provides low-cost health coverage to children in families that earn too much money to qualify for Medicaid. The program is bipartisan enactment from the late 1990s and covers over nine...

December 4, 2017

There they go again. Yesterday, CVS Health announced it has agreed to build the health insurance company Aetna for $69 billion in a massive deal that combine drugstores, a PBM, and a health insurer into one mega-corporation. This deal would reshape the health care indu...

Please reload

Featured Posts

United States-Mexico-Canada Agreement (USMCA)

October 5, 2018

Please reload

Recent Posts
Please reload